申请人:Principia Biopharma, Inc.
公开号:US10294223B2
公开(公告)日:2019-05-21
Compounds that are Fibroblast Growth Factor Inhibitors (FGFR) and are therefore useful for the treatment of diseases treatable by inhibition of FGFR are disclosed. Also disclosed are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
本发明公开了成纤维细胞生长因子抑制剂(FGFR),因此可用于治疗可通过抑制 FGFR 治疗的疾病的化合物。还公开了含有此类化合物的药物组合物和制备此类化合物的工艺。